Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tissue Transplantation01:24

Tissue Transplantation

Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Lung transplantation in a recipient with novel 2009 H1N1 influenza: lessons learned.

The Thoracic and cardiovascular surgeon·2011
Same author

The effect of recipient hepatitis C virus infection on outcomes following heart transplantation.

Transplantation proceedings·2010
Same author

Lung transplantation: past, present, and future.

Minerva chirurgica·2009
Same author

Donors of hearts with increased left ventricular wall thickness: the unresolved issue.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2008
Same author

Mannitol-induced hyperosmolal hyponatraemia.

Internal medicine journal·2008
Same author

Rantes production during development of cardiac allograft vasculopathy.

Transplantation·2001
Same journal

Unexpected evolution of COVID-19 in a heart transplant patient with multimorbidity recently submitted to thoracic surgery.

Minerva chirurgica·2020
Same journal

Ongoing clinical trials on axillary management.

Minerva chirurgica·2020
Same journal

Axillary management after neoadjuvant treatment.

Minerva chirurgica·2020
Same journal

Axillary observation alone versus sentinel node biopsy: past, present and future perspectives.

Minerva chirurgica·2020
Same journal

Patient flow for the management of ostomy patients.

Minerva chirurgica·2020
Same journal

The management of "fragile" and suspected COVID-19 surgical patients during pandemic: an Italian single-center experience.

Minerva chirurgica·2020
See all related articles

Related Experiment Video

Updated: Jun 24, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

Heart transplantation.

J J Yun1, G Gonzalez-Stawinski

  • 1Department of Cardiothoracic Surgery, Cleveland Clinic Foundation, Cleveland, OH, USA.

Minerva Chirurgica
|February 10, 2009
PubMed
Summary
This summary is machine-generated.

Heart transplantation is a common treatment for end-stage heart failure, with over 3000 procedures annually. However, long-term survival is limited, necessitating advancements in organ availability and rejection therapies.

More Related Videos

A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft
08:30

A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft

Published on: February 14, 2022

A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death
07:08

A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death

Published on: June 6, 2025

Related Experiment Videos

Last Updated: Jun 24, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft
08:30

A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft

Published on: February 14, 2022

A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death
07:08

A High-Fidelity Porcine Model of Orthotopic Heart Transplantation Following Donation after Circulatory Death

Published on: June 6, 2025

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Regenerative Medicine

Background:

  • Heart transplantation has evolved into a standard therapy for end-stage heart failure over the last four decades.
  • More than 3000 heart transplantations are performed each year globally.
  • Despite significant progress, long-term patient survival post-transplantation remains a critical challenge.

Observation:

  • Short-term outcomes following heart transplantation have shown marked improvement.
  • Long-term survival rates continue to be a significant limitation in heart transplant recipients.
  • Ongoing research focuses on addressing key challenges in the field.

Findings:

  • The primary challenges in heart transplantation include donor organ scarcity.
  • Developing robust treatments for chronic organ rejection is crucial.
  • Enhancing mechanical circulatory support systems for advanced heart failure is an active area of investigation.

Implications:

  • Alleviating the donor organ shortage is paramount for increasing transplant accessibility.
  • Effective management of chronic rejection is essential for improving long-term graft survival.
  • Advancements in mechanical support offer alternative or adjunctive strategies for heart failure management.